Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-01

Clinical Trial Update: Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression [NA]

View source ↗

Summary

This ClinicalTrials.gov entry updates a study evaluating Zuojin Wan combined with Rabeprazole or Mosapride for functional dyspepsia with depression; the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mosapride (mosapride)
  • Rabeprazole (rabeprazole)
  • Zuojin Wan

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Functional Dyspepsia, Depression | NA | Status: NOT_YET_RECRUITING